SNHG3 and hepatocellular carcinoma: The results demonstrated that overexpressed SNHG3 was significantly associated with poor OS in various cancers (HR = 2.53, 95% CI: 1.94-3.31) and poor DFS (HR = 3.89, 95% CI: 1.34-11.3) and RFS (HR = 2.42, 95% CI: 1.14-5.15) in hepatocellular carcinoma.